A61K8/375

HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE
20180000992 · 2018-01-04 ·

Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. The present hyaluronic acid-based compositions including lidocaine have an enhanced stability and cohesivity, relative to conventional compositions including lidocaine, for example when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such hyaluronic acid-based compositions are also provided.

Hair treatment compositions containing pectin and cationic compounds

The instant disclosure relates to hair treatment compositions that include a unique combination of components that function to impart desirable cosmetic properties to the hair. The hair treatment compositions typically include a cationic cellulosic quaternary ammonium compound; pectin; a cationic surfactant including cationizable surfactants together with an acid neutralizer; glyceryl ester; fatty alcohol; polyol; and water; wherein the weight ratio of the cationic cellulosic quaternary ammonium compound to pectin is from about 0.5 to about 5.

FIBROUS STRUCTURES COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS

A composition comprising a metathesized polyol ester that may be combined with a fibrous structure, including a wipe.

SHELL-FREE STABLE DISPERSION
20230233422 · 2023-07-27 ·

A dispersion comprises a dispersed phase comprising drops and a continuous aqueous phase, preferably in gel form, wherein the drops comprise a fatty phase comprising at least one lipophilic gelling agent, wherein: the fatty phase has a melting point between 50° C. and 100° C., preferably between 60° C. and 90° C., and, at room temperature and atmospheric pressure, meets the following physicochemical criteria: a hardness (x) of between 2 and 14 N, preferably between 2.5 and 12 N, more preferably between 3 and 9 N, and most preferably between 4 and 6 N; and an adhesiveness (y) greater than or equal to −2 N, and better still, greater than or equal to −1 N, and in particular greater than or equal to −0.6 N; and the dispersion does not comprise amodimethicone.

ALCOHOL BASED SANITIZER WITH IMPROVED DERMAL COMPATIBILITY AND FEEL
20230000740 · 2023-01-05 ·

Applicants have identified a critical skin benefit package that can be used in liquid alcohol sanitizing compositions that provides lower amounts of skin conditioners in combination with a specific ratio of different emollients that provide improved skin health with chronic repeated use. The package also provides improved skin feel with without a tacky residue upon drying.

COLOR-STABLE SUNSCREEN

Cosmetic preparation containing a) 4-(tert.-butyl)-4′-methoxydibenzoyl methane and/or (2-[-4-(diethylamino)-2-hydroxybenzoyl] benzoic acid hexyl ester (INCI: Diethylamino Hydroxybenzoyl Hexyl Benzoate) and b) diisostearoyl polyglyceryl-3-dimer-dilinoleate.

COSMETIC COMPOSITION FOR IMPROVED BLEACHING OR DYEING OF KERATIN FIBERS
20230000747 · 2023-01-05 · ·

A cosmetic composition for improved dyeing of keratin fibers is described. The composition comprises alkoxylated organopolysiloxanes and alkoxylated glyceryl esters and/or optionally alkoxylated alkyl glyceryl ethers. The composition may comprise less than 40 wt % water, or may be anhydrous. The composition may further comprise a direct dye, and may be used for bleaching, lightening, or dyeing of keratin fibers.

POLYOL ESTERS FROM BIOBASED FEEDSTOCKS FOR USE AS EMOLLIENT IN PERSONAL CARE APPLICATIONS

Provided are personal care compositions comprising ester polyol esters, ester polyol esters, manufacturing methods thereof, and the use of ester polyol esters in personal care compositions.

Hygiene Product Pod and Methods of Using Same

Disclosed herein are hygiene product pods and a method of using the hygiene product pods. A hygiene product pod can include a water-soluble envelope and a hygiene product sealed in the water-soluble envelope. A hygiene product as described herein can comprise a non-aqueous carrier. A non-aqueous carrier as described herein can comprise a polyol solvent and a polyglyceryl fatty acid ester (PGEs) chassis.

PPAR AGONIST COMPLEX AND METHODS OF USE
20230000759 · 2023-01-05 ·

Compositions and topical formulations comprising a PPAR agonist complex comprising glyceryl linoleate, glyceryl linolenate, xymenynic acid, and Pterocarpus marsupium bark extract are described herein. Methods of inducing skin barrier repair, increasing the biosynthesis of barrier lipids and proteins in the skin, stimulating hair growth, treating acne and combinations thereof utilizing the composition and topical formulations are also provided herein.